{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T08:07:00Z","timestamp":1788336420468,"version":"build-2803163510"},"reference-count":51,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2012,1,3]],"date-time":"2012-01-03T00:00:00Z","timestamp":1325548800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0029541","type":"journal-article","created":{"date-parts":[[2012,1,4]],"date-time":"2012-01-04T00:47:11Z","timestamp":1325638031000},"page":"e29541","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":92,"title":["miR-122 Regulates p53\/Akt Signalling and the Chemotherapy-Induced Apoptosis in Cutaneous T-Cell Lymphoma"],"prefix":"10.1371","volume":"7","author":[{"given":"Valentina","family":"Manf\u00e8","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edyta","family":"Biskup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Rosbjerg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Kamstrup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Guldhammer","family":"Skov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catharina Margrethe","family":"Lerche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Britt Thyssing","family":"Lauenborg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels","family":"\u00d8dum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Gniadecki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2012,1,3]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","article-title":"WHO-EORTC classification for cutaneous lymphomas.","volume":"105","author":"R Willemze","year":"2005","journal-title":"Blood"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1002\/cncr.11593","article-title":"Multicenter study of pegylated liposomal doxorubicin in patients with cutaneous T-cell lymphoma.","volume":"98","author":"U Wollina","year":"2003","journal-title":"Cancer"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1200\/JCO.2000.18.13.2603","article-title":"Gemcitabine treatment in pretreated cutaneous T-cell lymphoma: experience in 44 patients.","volume":"18","author":"PL Zinzani","year":"2000","journal-title":"J Clin Oncol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"3797","DOI":"10.1182\/blood-2003-03-0899","article-title":"Bone marrow precursor of extranodal T-cell lymphoma.","volume":"102","author":"R Gniadecki","year":"2003","journal-title":"Blood"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"3648","DOI":"10.1158\/1078-0432.CCR-10-0671","article-title":"Pralatrexate is synergistic with the proteasome inhibitor bortezomib in in vitro and in vivo models of T-cell lymphoid malignancies.","volume":"16","author":"E Marchi","year":"2010","journal-title":"Clin Cancer Res"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S1074-7613(00)80054-0","article-title":"Deficient T cell fate specification in mice with an induced inactivation of Notch1.","volume":"10","author":"F Radtke","year":"1999","journal-title":"Immunity"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.immuni.2010.01.004","article-title":"Notch signaling in the immune system.","volume":"32","author":"F Radtke","year":"2010","journal-title":"Immunity"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.bcp.2010.03.026","article-title":"Notch signaling: emerging molecular targets for cancer therapy.","volume":"80","author":"L Yin","year":"2010","journal-title":"Biochem Pharmacol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/0092-8674(91)90111-B","article-title":"TAN-1, the human homolog of the Drosophila notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms.","volume":"66","author":"LW Ellisen","year":"1991","journal-title":"Cell"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1126\/science.1102160","article-title":"Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia.","volume":"306","author":"AP Weng","year":"2004","journal-title":"Science"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1210\/er.2006-0046","article-title":"Notch signaling in development and cancer.","volume":"28","author":"V Bolos","year":"2007","journal-title":"Endocr Rev"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/30756","article-title":"Notch-1 signalling requires ligand-induced proteolytic release of intracellular domain.","volume":"393","author":"EH Schroeter","year":"1998","journal-title":"Nature"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"7672","DOI":"10.1158\/0008-5472.CAN-09-1843","article-title":"Preclinical profile of a potent gamma-secretase inhibitor targeting notch signaling with in vivo efficacy and pharmacodynamic properties.","volume":"69","author":"L Luistro","year":"2009","journal-title":"Cancer Res"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/j.1365-2133.2007.08427.x","article-title":"Potential involvement of Notch1 signalling in the pathogenesis of primary cutaneous CD30-positive lymphoproliferative disorders.","volume":"158","author":"MR Kamstrup","year":"2008","journal-title":"Br J Dermatol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1182\/blood-2009-12-260216","article-title":"Notch1 as a potential therapeutic target in cutaneous T-cell lymphoma.","volume":"116","author":"MR Kamstrup","year":"2010","journal-title":"Blood"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"6598","DOI":"10.1038\/sj.onc.1206758","article-title":"Notch signaling as a therapeutic target in cancer: a new approach to the development of cell fate modifying agents.","volume":"22","author":"BJ Nickoloff","year":"2003","journal-title":"Oncogene"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.cell.2009.01.035","article-title":"Origins and Mechanisms of miRNAs and siRNAs.","volume":"136","author":"RW Carthew","year":"2009","journal-title":"Cell"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ydbio.2006.08.028","article-title":"microRNAs as oncogenes and tumor suppressors.","volume":"302","author":"B Zhang","year":"2007","journal-title":"Dev Biol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/nature02871","article-title":"The functions of animal microRNAs.","volume":"431","author":"V Ambros","year":"2004","journal-title":"Nature"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1126\/science.1065329","article-title":"An extensive class of small RNAs in Caenorhabditis elegans.","volume":"294","author":"RC Lee","year":"2001","journal-title":"Science"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/nrc1997","article-title":"MicroRNA signatures in human cancers.","volume":"6","author":"GA Calin","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"e235","DOI":"10.1016\/j.leukres.2010.03.035","article-title":"Changes in oncomiR expression in CTCL cell lines during apoptosis induced by Notch inhibition.","volume":"34","author":"V Manfe","year":"2010","journal-title":"Leuk Res"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"3526","DOI":"10.1038\/onc.2009.211","article-title":"Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties.","volume":"28","author":"C Coulouarn","year":"2009","journal-title":"Oncogene"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"5761","DOI":"10.1158\/0008-5472.CAN-08-4797","article-title":"MiR-122\/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells.","volume":"69","author":"F Fornari","year":"2009","journal-title":"Cancer Res"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1084\/jem.154.5.1403","article-title":"Human cutaneous T cell lymphoma and leukemia cell lines produce and respond to T cell growth factor.","volume":"154","author":"JE Gootenberg","year":"1981","journal-title":"J Exp Med"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/BF00431220","article-title":"A continuous T-cell line from a patient with Sezary syndrome.","volume":"279","author":"K Kaltoft","year":"1987","journal-title":"Arch Dermatol Res"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1182\/blood.V55.3.409.409","article-title":"Mitogen requirements for the in vitro propagation of cutaneous T-cell lymphomas.","volume":"55","author":"AF Gazdar","year":"1980","journal-title":"Blood"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1182\/blood-2007-06-095182","article-title":"IL-2- and IL-15-induced activation of the rapamycin-sensitive mTORC1 pathway in malignant CD4+ T lymphocytes.","volume":"111","author":"M Marzec","year":"2008","journal-title":"Blood"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1182\/blood-2007-03-055749","article-title":"Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC).","volume":"110","author":"E Olsen","year":"2007","journal-title":"Blood"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"e201","DOI":"10.1111\/j.1600-0625.2009.01049.x","article-title":"Reproducible pattern of microRNA in normal human skin.","volume":"19","author":"LM Holst","year":"2010","journal-title":"Exp Dermatol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1261\/rna.939908","article-title":"Normalization of microRNA expression levels in quantitative RT-PCR assays: identification of suitable reference RNA targets in normal and cancerous human solid tissues.","volume":"14","author":"HJ Peltier","year":"2008","journal-title":"RNA"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.ymeth.2010.07.002","article-title":"Robust one-day in situ hybridization protocol for detection of microRNAs in paraffin samples using LNA probes.","volume":"52","author":"S Jorgensen","year":"2010","journal-title":"Methods"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1038\/sj.jid.5700322","article-title":"The selective protein kinase C beta inhibitor enzastaurin induces apoptosis in cutaneous T-cell lymphoma cell lines through the AKT pathway.","volume":"126","author":"C Querfeld","year":"2006","journal-title":"J Invest Dermatol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1182\/blood-2005-06-2536","article-title":"Down-regulating constitutive activation of the NF-kappaB canonical pathway overcomes the resistance of cutaneous T-cell lymphoma to apoptosis.","volume":"107","author":"A Sors","year":"2006","journal-title":"Blood"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/nrc2675","article-title":"Crosstalk of Notch with p53 and p63 in cancer growth control.","volume":"9","author":"GP Dotto","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1126\/science.1092472","article-title":"In vivo activation of the p53 pathway by small-molecule antagonists of MDM2.","volume":"303","author":"LT Vassilev","year":"2004","journal-title":"Science"},{"key":"ref37","article-title":"Bortezomib-induced apoptosis in mature T-cell lymphoma cells partially depends on upregulation of Noxa and functional repression of Mcl-1.","author":"M Ri","year":"2008","journal-title":"Cancer Sci"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"3102","DOI":"10.1158\/1078-0432.CCR-04-1857","article-title":"Inhibition of phosphatidylinositol 3\u2032-kinase\/AKT signaling promotes apoptosis of primary effusion lymphoma cells.","volume":"11","author":"S Uddin","year":"2005","journal-title":"Clin Cancer Res"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"18261","DOI":"10.1073\/pnas.0606108103","article-title":"NOTCH1 directly regulates c-MYC and activates a feed-forward-loop transcriptional network promoting leukemic cell growth.","volume":"103","author":"T Palomero","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1038\/nm1636","article-title":"Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia.","volume":"13","author":"T Palomero","year":"2007","journal-title":"Nat Med"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"7106","DOI":"10.1128\/JVI.77.12.7106-7112.2003","article-title":"Activated Notch1 inhibits p53-induced apoptosis and sustains transformation by human papillomavirus type 16 E6 and E7 oncogenes through a PI3K-PKB\/Akt-dependent pathway.","volume":"77","author":"P Nair","year":"2003","journal-title":"J Virol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1600-0560.1999.tb01860.x","article-title":"p53 tumor suppressor gene mutations in transformed cutaneous T-cell lymphoma: a study of 12 cases.","volume":"26","author":"AJ Marrogi","year":"1999","journal-title":"J Cutan Pathol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1046\/j.1523-1747.1998.00167.x","article-title":"Overexpression of p53 protein in cutaneous T cell lymphoma: relationship to large cell transformation and disease progression.","volume":"110","author":"G Li","year":"1998","journal-title":"J Invest Dermatol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1067\/mob.2003.140","article-title":"Increased expression of cyclin G1 in leiomyoma compared with normal myometrium.","volume":"188","author":"WK Baek","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"3290","DOI":"10.1038\/sj.onc.1204270","article-title":"Cyclin G1 is involved in G2\/M arrest in response to DNA damage and in growth control after damage recovery.","volume":"20","author":"SH Kimura","year":"2001","journal-title":"Oncogene"},{"key":"ref46","first-page":"195","article-title":"Cyclin G1 has growth inhibitory activity linked to the ARF-Mdm2-p53 and pRb tumor suppressor pathways.","volume":"1","author":"L Zhao","year":"2003","journal-title":"Mol Cancer Res"},{"key":"ref47","article-title":"microRNAs: Master Regulators as Potential Therapeutics in Cancer.","author":"M Garofalo","year":"2010","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.bbamcr.2010.06.013","article-title":"MicroRNAs: synthesis, mechanism, function, and recent clinical trials.","volume":"1803","author":"F Wahid","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1038\/nature06783","article-title":"LNA-mediated microRNA silencing in non-human primates.","volume":"452","author":"J Elmen","year":"2008","journal-title":"Nature"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1126\/science.1178178","article-title":"Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection.","volume":"327","author":"RE Lanford","year":"2010","journal-title":"Science"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.semcancer.2008.01.004","article-title":"The utility of LNA in microRNA-based cancer diagnostics and therapeutics.","volume":"18","author":"J Stenvang","year":"2008","journal-title":"Semin Cancer Biol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0029541","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,30]],"date-time":"2020-06-30T00:28:37Z","timestamp":1593476917000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0029541"}},"subtitle":[],"editor":[{"given":"Pierre","family":"Bob\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,1,3]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2012,1,3]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0029541","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,1,3]]}}}